Carregant...
Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor
Secondary glioblastoma is a rare brain tumor characterized by a mutation in isocitrate dehydrogenase, which is reported to lead to epigenetic modification. Patients with secondary glioblastoma experience poor survival and quality-of-life outcomes due to the disease’s aggressiveness and a lack of tar...
Guardat en:
| Publicat a: | Oxf Med Case Reports |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7104214/ https://ncbi.nlm.nih.gov/pubmed/32257248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omaa006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|